HISTORICAL PERSPECTIVES ON YALE PHARMACOLOGY
The Department of Pharmacology at Yale has a renowned history since its inception in the 1940s by William Salter. Most notably, it has led the world in the study of cancer chemotherapy and neuropharmacology. Indeed, modem cancer chemotherapy took flight at Yale in 1942 when Alfred Gilman and Louis Goodman discovered the first anticancer drug for lymphoma when they demonstrated the effects of nitrogen mustard in reducing transplanted lymphosarcoma in mice (Gilman et al., 1963) .
In 1953, Arnold Welch came to Yale from Oxford to become the departmental chair. He took over an anemic department and began to recruit young scientists who would prove to be the best in the country. John Vane shared the Nobel Prize in 1982 for his work on prostaglandins and prostacyclin and the mechanism of action of aspirin. William Prusoff discovered the first specific antiviral drug to be used in man, 5-Iododeoxyuridine (IUdR) for the treatment of ocular herpes and later found the first drug against human immunodeficiency virus, 3'-deoxythymidin-2'-ene (d4T) (Lin TS et al., 1987 
